Nitric oxide synthase (NOS3) variants and disease-free survival among treated and untreated breast cancer patients in a SWOG Clinical Trial (S8897)

PURPOSE: Numerous chemotherapeutic agents are cytotoxic through generation of reactive species, and variability in genes related to oxidative stress may influence disease free survival (DFS). We examined relationships between DFS and variants in NOS3, as well as NQO1, NQO2 and CBR3 among treated and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Choi, Ji-Yeob, Barlow, William E., Albain, Kathy S., Hong, Chi-Chen, Blanco, Javier G., Livingston, Robert B., Davis, Warren, Rae, James M., Yeh, I-Tien, Hutchins, Laura F., Ravdin, Peter M., Martino, Silvana, Lyss, Alan P., Osborne, C. Kent, Abeloff, Martin D., Hayes, Daniel F., Ambrosone, Christine B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745926/
https://ncbi.nlm.nih.gov/pubmed/19671875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0685
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados